BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

291 related articles for article (PubMed ID: 28648578)

  • 1. Application of aptamers in treatment and diagnosis of leukemia.
    Yazdian-Robati R; Arab A; Ramezani M; Abnous K; Taghdisi SM
    Int J Pharm; 2017 Aug; 529(1-2):44-54. PubMed ID: 28648578
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Aptamer application in targeted delivery systems for diagnosis and treatment of breast cancer.
    Shahdordizadeh M; Yazdian-Robati R; Ramezani M; Abnous K; Taghdisi SM
    J Mater Chem B; 2016 Dec; 4(48):7766-7778. PubMed ID: 32263769
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Aptamer-drug conjugation for targeted tumor cell therapy.
    Donovan MJ; Meng L; Chen T; Zhang Y; Sefah K; Tan W
    Methods Mol Biol; 2011; 764():141-52. PubMed ID: 21748638
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Recent Advances in SELEX Technology and Aptamer Applications in Biomedicine.
    Zhuo Z; Yu Y; Wang M; Li J; Zhang Z; Liu J; Wu X; Lu A; Zhang G; Zhang B
    Int J Mol Sci; 2017 Oct; 18(10):. PubMed ID: 29036890
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Advances of aptamers screened by Cell-SELEX in selection procedure, cancer diagnostics and therapeutics.
    Zhong Y; Zhao J; Li J; Liao X; Chen F
    Anal Biochem; 2020 Jun; 598():113620. PubMed ID: 32087127
    [TBL] [Abstract][Full Text] [Related]  

  • 6. SELEX methods on the road to protein targeting with nucleic acid aptamers.
    Bayat P; Nosrati R; Alibolandi M; Rafatpanah H; Abnous K; Khedri M; Ramezani M
    Biochimie; 2018 Nov; 154():132-155. PubMed ID: 30193856
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Voltammetric aptasensors for protein disease biomarkers detection: A review.
    Meirinho SG; Dias LG; Peres AM; Rodrigues LR
    Biotechnol Adv; 2016; 34(5):941-953. PubMed ID: 27235188
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Oligonucleotide aptamers: Recent advances in their screening, molecular conformation and therapeutic applications.
    Xiao X; Li H; Zhao L; Zhang Y; Liu Z
    Biomed Pharmacother; 2021 Nov; 143():112232. PubMed ID: 34649356
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Aptamers targeting cell surface proteins.
    Takahashi M
    Biochimie; 2018 Feb; 145():63-72. PubMed ID: 29198584
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A Highlight of Recent Advances in Aptamer Technology and Its Application.
    Sun H; Zu Y
    Molecules; 2015 Jun; 20(7):11959-80. PubMed ID: 26133761
    [TBL] [Abstract][Full Text] [Related]  

  • 11. SELEX--a (r)evolutionary method to generate high-affinity nucleic acid ligands.
    Stoltenburg R; Reinemann C; Strehlitz B
    Biomol Eng; 2007 Oct; 24(4):381-403. PubMed ID: 17627883
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Progress and Challenges in Developing Aptamer-Functionalized Targeted Drug Delivery Systems.
    Jiang F; Liu B; Lu J; Li F; Li D; Liang C; Dang L; Liu J; He B; Badshah SA; Lu C; He X; Guo B; Zhang XB; Tan W; Lu A; Zhang G
    Int J Mol Sci; 2015 Oct; 16(10):23784-822. PubMed ID: 26473828
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Aptamers evolved from cultured cancer cells reveal molecular differences of cancer cells in patient samples.
    Shangguan D; Cao ZC; Li Y; Tan W
    Clin Chem; 2007 Jun; 53(6):1153-5. PubMed ID: 17463173
    [TBL] [Abstract][Full Text] [Related]  

  • 14. FFF-based high-throughput sequence shortlisting to support the development of aptamer-based analytical strategies.
    Marassi V; Mattarozzi M; Toma L; Giordani S; Ronda L; Roda B; Zattoni A; Reschiglian P; Careri M
    Anal Bioanal Chem; 2022 Jul; 414(18):5519-5527. PubMed ID: 35182166
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Progress in selection and biomedical applications of aptamers.
    Xi Z; Huang R; Deng Y; He N
    J Biomed Nanotechnol; 2014 Oct; 10(10):3043-62. PubMed ID: 25992428
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Targeted delivery of daunorubicin to T-cell acute lymphoblastic leukemia by aptamer.
    Taghdisi SM; Abnous K; Mosaffa F; Behravan J
    J Drug Target; 2010 May; 18(4):277-81. PubMed ID: 19943768
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Aptamers Targeting Membrane Proteins for Sensor and Diagnostic Applications.
    Kara N; Ayoub N; Ilgu H; Fotiadis D; Ilgu M
    Molecules; 2023 Apr; 28(9):. PubMed ID: 37175137
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Post-SELEX optimization of aptamers.
    Gao S; Zheng X; Jiao B; Wang L
    Anal Bioanal Chem; 2016 Jul; 408(17):4567-73. PubMed ID: 27173394
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Trends in aptamer selection methods and applications.
    YĆ¼ce M; Ullah N; Budak H
    Analyst; 2015 Aug; 140(16):5379-99. PubMed ID: 26114391
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The influence of food matrices on aptamer selection by SELEX (systematic evolution of ligands by exponential enrichment) targeting the norovirus P-Domain.
    Schilling KB; DeGrasse J; Woods JW
    Food Chem; 2018 Aug; 258():129-136. PubMed ID: 29655714
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.